Peptide Vaccine: clinical trials recruiting now

Fewer than 3 recruiting trials found.

2

Recruiting trials

9

Conditions studied

2

US states with sites

1

Countries

Phase breakdown

Phase 1 2 Phase 2 1

Conditions being studied

Condition	Trials
ALK Fusion Protein Expression	1
Chronic Kidney Disease, Stage 4	1
Chronic Kidney Disease, Stage 5	1
Chronic kidney disease	1
EBV-Related Lymphoproliferative Disorder	1
EBV-Related Malignant Neoplasm	1
Lung cancer	1
NSCLC Stage IV	1
Post-Transplant Lymphoproliferative Disorder	1

Recruiting trials involving Peptide Vaccine

BZLF1 Peptide Vaccine (OSU-2131) With QS-21 for the Prevention of Epstein-Barr Virus Related Cancer in Patients Awaiting Solid Organ Transplants
NCT06741072 · Phase: Phase 1 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 1 location
Peptide Vaccine To Prevent Acquired Resistance In Patients With Advanced ALK+ NSCLC
NCT05950139 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location

Common questions

How many recruiting trials involve Peptide Vaccine?

2 recruiting trials across 9 conditions.

Is this list of trials complete?

No. For the full record, search ClinicalTrials.gov.

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.